Lithium - Columbia Northwest Pharmaceuticals
Latest Information Update: 03 Sep 2015
At a glance
- Originator Columbia Northwest Pharmaceuticals
- Class Alkali metals; Antidepressants; Antimanics; Antipsychotics; Light metals
- Mechanism of Action Adrenergic uptake modulators; Serotonin release stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Suicidal ideation
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 22 Apr 2010 Phase-II clinical trials in Suicidal ideation in USA (PO)